Literature DB >> 18332074

Amino acid cerebrospinal fluid/plasma ratios in children: influence of age, gender, and antiepileptic medication.

Sabine Scholl-Bürgi1, Edda Haberlandt, Peter Heinz-Erian, Florian Deisenhammer, Ursula Albrecht, Sara Baumgartner Sigl, Markus Rauchenzauner, Hanno Ulmer, Daniela Karall.   

Abstract

OBJECTIVE: The purpose of this work was to investigate the influence of age, gender, and antiepileptic therapy on amino acid cerebrospinal fluid/plasma ratios in children. PATIENTS AND METHODS: Concentrations of 17 amino acids measured by ion-exchange chromatography with ninhydrin detection in plasma and cerebrospinal fluid from 68 patients with neurologic diseases were used to calculate their cerebrospinal fluid/plasma ratios (70 measurements; 28 female patients [29 punctures] and 40 male patients [41 punctures]). Age dependence and the effects of gender and antiepileptic medication on amino acid cerebrospinal fluid/plasma ratios were investigated by linear multiple regression analysis, and nonstandardized predicted mean values for 2 age groups were calculated (cutoff: 3 years old).
RESULTS: The cerebrospinal fluid/plasma ratios ranged between 0.02 for glycine and 0.93 for glutamine. Age had a significant influence on cerebrospinal fluid/plasma ratios for valine, isoleucine, leucine, and tyrosine, with higher ratios in younger children. Gender had a significant influence only on the glutamine cerebrospinal fluid/plasma ratio (female patients had lower ratios). Cerebrospinal fluid/plasma ratios of glutamine and tyrosine were significantly elevated by valproate therapy and those of serine, asparagine, glutamine, valine, methionine, and phenylalanine by phenobarbital therapy. No significant influence of age, gender, and antiepileptic drugs was detectable on cerebrospinal fluid/plasma ratios of threonine, proline, glycine, alanine, histidine, ornithine, lysine, and arginine.
CONCLUSIONS: Cerebrospinal fluid/plasma ratios, especially for essential neutral amino acids and for serine, asparagine, and glutamine were influenced to different degrees by age, gender, and antiepileptic therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18332074     DOI: 10.1542/peds.2007-1631

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  18 in total

Review 1.  Asparagine synthetase: Function, structure, and role in disease.

Authors:  Carrie L Lomelino; Jacob T Andring; Robert McKenna; Michael S Kilberg
Journal:  J Biol Chem       Date:  2017-10-30       Impact factor: 5.157

2.  Distinct plasma profile of polar neutral amino acids, leucine, and glutamate in children with Autism Spectrum Disorders.

Authors:  Rabindra Tirouvanziam; Tetyana V Obukhanych; Julie Laval; Pavel A Aronov; Robin Libove; Arpita Goswami Banerjee; Karen J Parker; Ruth O'Hara; Leonard A Herzenberg; Leonore A Herzenberg; Antonio Y Hardan
Journal:  J Autism Dev Disord       Date:  2012-05

3.  Characterization of a novel variant in siblings with Asparagine Synthetase Deficiency.

Authors:  Stephanie J Sacharow; Elizabeth E Dudenhausen; Carrie L Lomelino; Lance Rodan; Christelle Moufawad El Achkar; Heather E Olson; Casie A Genetti; Pankaj B Agrawal; Robert McKenna; Michael S Kilberg
Journal:  Mol Genet Metab       Date:  2017-12-20       Impact factor: 4.797

4.  Amino Acid Dysregulation Metabotypes: Potential Biomarkers for Diagnosis and Individualized Treatment for Subtypes of Autism Spectrum Disorder.

Authors:  Alan M Smith; Joseph J King; Paul R West; Michael A Ludwig; Elizabeth L R Donley; Robert E Burrier; David G Amaral
Journal:  Biol Psychiatry       Date:  2018-09-06       Impact factor: 13.382

Review 5.  Amino acid metabolism in patients with propionic acidaemia.

Authors:  Sabine Scholl-Bürgi; Jörn Oliver Sass; Johannes Zschocke; Daniela Karall
Journal:  J Inherit Metab Dis       Date:  2010-11-27       Impact factor: 4.982

6.  Understanding pyrroline-5-carboxylate synthetase deficiency: clinical, molecular, functional, and expression studies, structure-based analysis, and novel therapy with arginine.

Authors:  Diego Martinelli; Johannes Häberle; Vicente Rubio; Cecilia Giunta; Ingrid Hausser; Rosalba Carrozzo; Nadine Gougeard; Clara Marco-Marín; Bianca M Goffredo; Maria Chiara Meschini; Elsa Bevivino; Sara Boenzi; Giovanna Stefania Colafati; Francesco Brancati; Matthias R Baumgartner; Carlo Dionisi-Vici
Journal:  J Inherit Metab Dis       Date:  2011-12-15       Impact factor: 4.982

7.  Amino acids in CSF and plasma in hyperammonaemic coma due to arginase1 deficiency.

Authors:  S Scholl-Bürgi; S Baumgartner Sigl; J Häberle; E Haberlandt; K Rostásy; C Ertl; U Eichinger-Öttl; P Heinz-Erian; D Karall
Journal:  J Inherit Metab Dis       Date:  2008-12-06       Impact factor: 4.982

8.  Deficiency of asparagine synthetase causes congenital microcephaly and a progressive form of encephalopathy.

Authors:  Elizabeth K Ruzzo; José-Mario Capo-Chichi; Bruria Ben-Zeev; David Chitayat; Hanqian Mao; Andrea L Pappas; Yuki Hitomi; Yi-Fan Lu; Xiaodi Yao; Fadi F Hamdan; Kimberly Pelak; Haike Reznik-Wolf; Ifat Bar-Joseph; Danit Oz-Levi; Dorit Lev; Tally Lerman-Sagie; Esther Leshinsky-Silver; Yair Anikster; Edna Ben-Asher; Tsviya Olender; Laurence Colleaux; Jean-Claude Décarie; Susan Blaser; Brenda Banwell; Rasesh B Joshi; Xiao-Ping He; Lysanne Patry; Rachel J Silver; Sylvia Dobrzeniecka; Mohammad S Islam; Abul Hasnat; Mark E Samuels; Dipendra K Aryal; Ramona M Rodriguiz; Yong-Hui Jiang; William C Wetsel; James O McNamara; Guy A Rouleau; Debra L Silver; Doron Lancet; Elon Pras; Grant A Mitchell; Jacques L Michaud; David B Goldstein
Journal:  Neuron       Date:  2013-10-16       Impact factor: 17.173

9.  Tolerability of inhaled N-chlorotaurine in the pig model.

Authors:  Ralf Geiger; Benedikt Treml; Anna Pinna; Linn Barnickel; Harald Prossliner; Hannes Reinstadler; Michael Pilch; Maria Hauer; Christoph Walther; Hans-Jörg Steiner; Thomas Giese; Andreas Wemhöner; Sabine Scholl-Bürgi; Waldemar Gottardi; Roland Arnitz; Consolato Sergi; Markus Nagl; Alexander Löckinger
Journal:  BMC Pulm Med       Date:  2009-07-14       Impact factor: 3.317

10.  Cerebrospinal Fluid Metabolomic Profiles Associated With Fatigue During Treatment for Pediatric Acute Lymphoblastic Leukemia.

Authors:  Austin L Brown; Pagna Sok; Olga Taylor; John P Woodhouse; M Brooke Bernhardt; Kimberly P Raghubar; Lisa S Kahalley; Philip J Lupo; Marilyn J Hockenberry; Michael E Scheurer
Journal:  J Pain Symptom Manage       Date:  2020-09-01       Impact factor: 3.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.